Skip to content
Screener

Nature's Sunshine Products NATR Cardiovascular — Net Sales

Other product segments

General health
$48.9M+3.2%
Digestive
$28.71M+2.9%
Immunity
$8.73M-13.4%
Personal care
$6.76M+27.4%
Weight management
$4.06M-12.0%

Similar metrics at other companies

Medtronic logo
MDTCardiovascular — Net Sales
$3.8B+13.8%
Boston Scientific logo
BSXCardiovascular — Net Sales
$3.62B+8.3%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%
Wabash National logo
WNCNew trailers — Net Sales
$317.05M+1.6%
Amazon logo
AMZNNet product sales — Net Sales
$71.3B+11.5%
Amazon logo
AMZNNet service sales — Net Sales
$110.22B+20.2%

Other financials

Income statement

See full
Revenue$117.0M+1.9%
Gross profit$86.2M+4.7%
Operating income$5.5M+28.2%
Net income$3.5M-33.7%
EPS (diluted)$0.19-32.1%

Balance sheet

See full
Cash & equivalents$82.5M+1.4%
Total debt$21.4M+37.1%
Total equity$169.3M+3.4%
Total assets$259.8M+1.9%

Cash flow

See full
Operating cash flow-$1.8M-171%
CapEx$2.8M+106%
Free cash flow-$1.9M-165%

Valuation

See full
Market cap$288.04M-2.3%
Enterprise value$226.97M-0.8%
P/E15.9×-4.5×
P/S0.6×-0.1×

Profitability

See full
Gross margin73.2%+1.4pp
Operating margin6%+1.6pp
Net margin3.7%+0.5pp
FCF margin3.7%-1.2pp

Returns & leverage

See full
Return on equity10.9%+1.9pp
Debt / equity0.1×0.0×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Nature's Sunshine Products in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Nature's Sunshine Products’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054468
Three Months Ended June 30, 2026AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$21,486$9,589$16,242$1,582$48,899
Immune3,0791,8833,3214478,730
Cardiovascular12,8252,8953,71339819,831
Digestive9,6016,50710,0812,51928,708
Personal care3,5301,1241,8792236,756
Weight management2,4766967151744,061
Total net sales by segment$52,997$22,694$35,951$5,343$116,985

Item 1. Financial Statements (Unaudited)

FAQ

What is Nature's Sunshine Products's cardiovascular — net sales?
Nature's Sunshine Products (NATR) reported cardiovascular — net sales of $19.83M in Q2 2026.
How has Nature's Sunshine Products's cardiovascular — net sales changed year-over-year?
Nature's Sunshine Products's cardiovascular — net sales increased by 1.9% year-over-year, from $19.46M to $19.83M.
What is the long-term trend for Nature's Sunshine Products's cardiovascular — net sales?
Over 4 years (2021 to 2025), Nature's Sunshine Products's cardiovascular — net sales has grown at a 1.1% compound annual growth rate (CAGR), from $78.03M to $81.64M.
What does cardiovascular — net sales mean?
This metric represents the total revenue generated from the sale of nutritional and wellness products specifically formulated to support cardiovascular health. It reflects the market demand and consumer adoption of the company's heart-health product portfolio within its broader wellness offerings. Tracking this figure helps investors assess the performance and growth trajectory of a key product category within the company's health and wellness segment.

Ask your AI about Nature's Sunshine Products's cardiovascular — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude